Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Limitations in the description of conformational preferences of C-disaccharides: The (1 → 3)-C-mannobiose case.

Raich I, Lövyová Z, Trnka L, Parkan K, Kessler J, Pohl R, Kaminský J.

Carbohydr Res. 2017 Nov 8;451:42-50. doi: 10.1016/j.carres.2017.09.006. Epub 2017 Sep 18.

PMID:
28950209
2.

Comparison of tuberculosis surveillance systems in low-incidence industrialised countries.

Mor Z, Migliori GB, Althomsons SP, Loddenkemper R, Trnka L, Iademarco MF.

Eur Respir J. 2008 Dec;32(6):1616-24. doi: 10.1183/09031936.00042908. Epub 2008 Aug 6.

3.

[How to continue in the treatment of tuberculosis in the Czech Republic?].

Trnka L, Wallenfels J.

Cas Lek Cesk. 2007;146(4):351-5; discussion 355-6. Czech.

PMID:
17491245
4.

Estrogen-induced cholestasis results in a dramatic increase of b-series gangliosides in the rat liver.

Majer F, Trnka L, Vítek L, Jirkovská M, Marecek Z, Smíd F.

Biomed Chromatogr. 2007 May;21(5):446-50.

PMID:
17357127
5.

[Tuberculosis in the Czech Republic in 2002].

Krejbich F, Trnka L, Mazánková V.

Cas Lek Cesk. 2003;142(12):746-50. Czech.

PMID:
14746224
6.

[Tuberculosis in the Czech Republic in the year 2000].

Trnka L, Danková D, Krejbich F.

Cas Lek Cesk. 2002 Jul 19;141(14):449-55. Czech.

PMID:
12238253
7.

Implementation of the DOTS strategy for tuberculosis in the Leningrad Region, Russian Federation (1998-1999).

Ruohonen RP, Goloubeva TM, Trnka L, Fomin MM, Zhemkova GA, Sinitsyn AV, Lichachev AA, Koskela KG.

Int J Tuberc Lung Dis. 2002 Mar;6(3):192-7.

PMID:
11934136
8.

[Multiresistant tuberculosis in the Czech Republic in 1998 and causes of its occurrence].

Krejbich F, Trnka L, Danková D.

Cas Lek Cesk. 2001 Jun 5;140(13):409-10. Czech.

PMID:
11507953
9.

Is quarterly cohort analysis useful for assessing treatment outcomes in a low incidence country?

Trnka L, Danková D, Krejbich F.

Int J Tuberc Lung Dis. 2001 Mar;5(3):250-6.

PMID:
11326824
10.

Screening of TB contacts by tuberculin skin tests in a low-incidence community by BCG vaccination.

Trnka L, Danková D, Krejbich F, Svandová E, Krenarová J, Spilka J.

Cent Eur J Public Health. 2001 Feb;9(1):26-9.

PMID:
11243585
11.

[Tuberculosis in the Czech Republic in 1999].

Trnka L, Danková D, Krejbich F, Svandová E.

Cas Lek Cesk. 2000 Nov 8;139(22):679-84. Czech.

PMID:
11191746
12.

[Tuberculosis in the Czech Republic in 1998].

Trnka L, Danková D, Krejbich F.

Cas Lek Cesk. 2000 Jun 7;139(11):323-8. Czech.

PMID:
10953410
13.

[Tuberculosis in the Czech Republic in 1997].

Trnka L, Krejbich F.

Cas Lek Cesk. 1999 Aug 2;138(15):460-4. Czech.

PMID:
10566219
14.

Tuberculosis control and surveillance in changing health reform in the Czech Republic.

Trnka L, Madaras AT, Krejbich F, Zatloukal P.

Med Arh. 1999;53(3 Suppl 1):11-2.

PMID:
10546460
15.

A cost-benefit analysis of BCG revaccination in the Czech Republic.

Pathania VS, Trnka L, Krejbich F, Dye C.

Vaccine. 1999 Apr 9;17(15-16):1926-35.

PMID:
10217591
16.

Survey of BCG vaccination policy in Europe: 1994-96.

Trnka L, Dankova D, Zitova J, Cimprichova L, Migliori GB, Clancy L, Zellweger JP.

Bull World Health Organ. 1998;76(1):85-91.

17.

[Tuberculosis in the Czech Republic in 1994. Does compulsory notification give a true picture of tuberculosis morbidity?].

Trnka L, Cimprichová L, Zítová J.

Cas Lek Cesk. 1996 Oct 23;135(20):653-6. Czech.

PMID:
8998810
19.

Validation of the surveillance system for new cases of tuberculosis in a province of northern Italy. Varese Tuberculosis Study Group.

Migliori GB, Spanevello A, Ballardini L, Neri M, Gambarini C, Moro ML, Trnka L, Raviglione MC.

Eur Respir J. 1995 Aug;8(8):1252-8.

21.
22.

The phenotype of alveolar macrophages and its correlation with immune cells in bronchoalveolar lavage.

Stríz I, Wang YM, Svarcová I, Trnka L, Sorg C, Costabel U.

Eur Respir J. 1993 Oct;6(9):1287-94.

PMID:
7904572
23.

Six years' experience with the discontinuation of BCG vaccination. 2. Cost and benefit of mass BCG vaccination.

Trnka L, Danková D, Svandová E.

Tuber Lung Dis. 1993 Aug;74(4):288-92.

PMID:
8219182
24.

[Surveillance of tuberculosis in the Czech Republic in 1991].

Trnka L, Hejdová E.

Cas Lek Cesk. 1993 Jun 28;132(13):401-5. Czech.

PMID:
8370052
25.

Six years' experience with the discontinuation of BCG vaccination. 1. Risk of tuberculosis infection and disease.

Trnka L, Danková D, Svandová E.

Tuber Lung Dis. 1993 Jun;74(3):167-72.

PMID:
8369510
26.

[Tuberculosis prevention needs adaptation to conditions of Central European countries].

Trnka L, Dankova D.

Probl Tuberk. 1993;(4):11-3. Russian.

PMID:
8127823
27.

[Tuberculosis surveillance in the Czech Republic in 1990].

Trnka L, Danková D.

Cas Lek Cesk. 1992 Mar 4;131(4):107-12. Czech.

PMID:
1581937
28.

Tuberculosis surveillance in the Czech Republic in 1989.

Trnka L, Danková D.

Czech Med. 1991;14(2):87-96.

PMID:
2070696
29.

[Surveillance of tuberculosis in the Czech Republic in 1989].

Trnka L, Danková D.

Cas Lek Cesk. 1990 Dec 7;129(49):1541-5. Czech.

PMID:
2265422
30.

First experience with BCG discontinuation in Europe. Project on discontinuation of BCG vaccination in newborns in Czechoslovakia.

Trnka L, Dankova D, Machova A, Svandova E, Hejdova E.

Bull Int Union Tuberc Lung Dis. 1990 Jun-Sep;65(2-3):36-7. No abstract available.

PMID:
2257353
31.

Surveillance systems and public health priority actions.

Trnka L, Dankova D, Erban J.

Bull Int Union Tuberc Lung Dis. 1990 Mar;65(1):37-8. No abstract available.

PMID:
2350610
32.
33.

[Tuberculosis control in Czechoslovakia in 1987].

Trnka L, Danková D.

Cas Lek Cesk. 1989 Jun 28;128(26):809-13. Czech.

PMID:
2790873
34.

The tuberculosis surveillance system in Czechoslovakia.

Dankova D, Trnka L.

Bull Int Union Tuberc Lung Dis. 1989 Mar;64(1):15-6. No abstract available.

PMID:
2743039
35.
36.

[Microepidemics of tuberculosis].

Danková D, Trnka L.

Z Erkr Atmungsorgane. 1989;173(1):37-9. German.

PMID:
2800612
37.

First experience with the project of discontinuation of BCG primovaccination in newborns in Czechoslovakia.

Trnka L, Dankova D.

Bull Int Union Tuberc Lung Dis. 1988 Dec;63(4):39. No abstract available.

PMID:
3228607
38.

[Tuberculosis in Czechoslovakia in 1985].

Trnka L, Danková D.

Cas Lek Cesk. 1987 May 4;126(18):560-5. Czech. No abstract available.

PMID:
3594530
39.

[Practical aspects of the serology and biology of legionellae].

Mison P, Strnad V, Stanková M, Skvor J, Kouba K, Trnka L.

Cas Lek Cesk. 1986 Jan 24;125(4):119-21. Czech. No abstract available.

PMID:
3512093
40.

[Legionnaires' disease in a 37-year-old man].

Stanková M, Mison P, Strnad V, Karpenková H, Kouba K, Trnka L.

Cas Lek Cesk. 1985 Jun 7;124(23):721-3. Czech. No abstract available.

PMID:
4016869
41.
42.

[Thank God, is it only tuberculosis?].

Trnka L.

Cas Lek Cesk. 1984 Oct 12;123(40-41):1217-22. Czech. No abstract available.

PMID:
6509464
43.

[Tuberculosis in children in Czechoslovakia in 1981 and 1982].

Trnka L, Danková D, Drápela J.

Cesk Pediatr. 1984 Feb;39(2):103-6. Czech. No abstract available.

PMID:
6335978
45.

[First-hand experience with serological diagnosis of legionellosis in Czechoslovakia].

Strnad V, Stanková M, Mison P, Trnka L, Kouba K, Mertenová J.

Cas Lek Cesk. 1982 Jul;121(28):865-9. Czech. No abstract available.

PMID:
7116394
46.

[Models of tuberculosis control in countries with low tuberculosis prevalence].

Trnka L, Trefný J.

Z Erkr Atmungsorgane. 1982;158(1-2):76-80. German.

PMID:
7072274
47.

[Campaign against tuberculosis in Czechoslovakia and perspectives for the future].

Trnka L, Trefny J.

Bull Int Union Tuberc. 1981 Mar-Jun;56(1-2):5-10. French. No abstract available.

PMID:
7296092
48.

[Tuberculosis control and its perspectives in Czechoslovakia].

Trnka L, Trefny J.

Cas Lek Cesk. 1981 Feb 12;120(6):145-9. Czech. No abstract available.

PMID:
7214442
49.

[Main signs of the epidemiological situation in tuberculosis and the forms of tuberculosis control in the Czechoslovak Socialist Republic].

Trefný J, Trnka L, Hejdová E.

Probl Tuberk. 1980 Sep;(9):8-10. Russian. No abstract available.

PMID:
7422666
50.

Supplemental Content

Support Center